According to IMARC Group’s latest report, titled “United States Biopsy Devices Market Report: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the United States biopsy devices market is currently witnessing moderate growth during 2015-2020. Looking forward, the market is expected to continue its moderate growth during the forecast period (2021-2026).
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Biopsy devices are different types of surgical equipment used to remove abnormal tissue, mass or tumor from an organ. They are also utilized by medical practitioners to diagnose the presence of cancerous or inflammatory diseases. Biopsy devices prevent crush artifacts and tissue fragmentation. On account of their light weight and compact size, biopsy devices are extensively used for performing MRI-guided, core, and vacuum-assisted and needle-based biopsies of different body parts.
Request Free Sample Report: https://www.imarcgroup.com/united-states-biopsy-devices-market/requestsample
Market Trends
The United States biopsy devices market is being primarily driven by the rising cases of cancer in the country. Moreover, there has been an increase in the number of minimally invasive (MI) surgeries being performed across the country, which is escalating the demand for these devices. The introduction of effective and advanced cancer diagnostic procedures is further propelling the market growth. Moreover, rapid advancements in the healthcare infrastructure and various favorable medical reimbursement policies are strengthening the market growth. Furthermore, various initiatives taken by the US Government to spread awareness regarding cancer and related symptoms are creating a positive outlook for the market.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/united-states-biopsy-devices-market
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market on the basis of procedure type, product, application, guidance technique, end user and region.
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Region:
- Northeast
- Midwest
- South
- West
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Follow us on Twitter: https://twitter.com/ImarcServices
